5 amino 1mq mechanism of action 5-Amino-1MQ Peptide: Benefits, Dosage & Safety (2026) 5-Amino-1MQ — NNMT Inhibition, NAD+

Cycle Duration No established protocol Repeatable Single cycle Key Considerations CRITICAL: No human clinical trials have been conducted All dosing information is from preclinical animal studies only Oral bioavailability in humans is unknown and uncharacterized Not FDA-approved or regulated as a pharmaceutical Community-reported doses lack clinical validation Subscribe to unlock this content Get weekly peptide research summaries, new study alerts, and protocol updates free

Effects on reproduction, pregnancy, and fetal development have not been evaluated

Preclinical safety data In mouse studies, 5-amino-1mq was well-tolerated even at doses several times higher than those producing metabolic effects

Does it affect methylation

The analogues, 1,8-diMQ and 5-amino-1MQ were tested at concentrations from 200 M 10 nM and 600 M 10 nM, respectively